Table of Content

1 Nonnarcotic Analgesics Market Overview
1.1 Nonnarcotic Analgesics Product Overview
1.2 Nonnarcotic Analgesics Market Segment by Type
1.2.1 Salicylates
1.2.2 Anilines
1.2.3 Pyrazolones
1.2.4 Other
1.3 Global Nonnarcotic Analgesics Market Size by Type
1.3.1 Global Nonnarcotic Analgesics Market Size Overview by Type (2018-2029)
1.3.2 Global Nonnarcotic Analgesics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Nonnarcotic Analgesics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nonnarcotic Analgesics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Nonnarcotic Analgesics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Nonnarcotic Analgesics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Nonnarcotic Analgesics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Nonnarcotic Analgesics Sales Breakdown by Type (2018-2024)
2 Global Nonnarcotic Analgesics Market Competition by Company
2.1 Global Top Players by Nonnarcotic Analgesics Sales (2018-2024)
2.2 Global Top Players by Nonnarcotic Analgesics Revenue (2018-2024)
2.3 Global Top Players by Nonnarcotic Analgesics Price (2018-2024)
2.4 Global Top Manufacturers Nonnarcotic Analgesics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nonnarcotic Analgesics Market Competitive Situation and Trends
2.5.1 Nonnarcotic Analgesics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nonnarcotic Analgesics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nonnarcotic Analgesics as of 2022)
2.7 Date of Key Manufacturers Enter into Nonnarcotic Analgesics Market
2.8 Key Manufacturers Nonnarcotic Analgesics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nonnarcotic Analgesics Status and Outlook by Region
3.1 Global Nonnarcotic Analgesics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Nonnarcotic Analgesics Historic Market Size by Region
3.2.1 Global Nonnarcotic Analgesics Sales in Volume by Region (2018-2024)
3.2.2 Global Nonnarcotic Analgesics Sales in Value by Region (2018-2024)
3.2.3 Global Nonnarcotic Analgesics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Nonnarcotic Analgesics Forecasted Market Size by Region
3.3.1 Global Nonnarcotic Analgesics Sales in Volume by Region (2024-2029)
3.3.2 Global Nonnarcotic Analgesics Sales in Value by Region (2024-2029)
3.3.3 Global Nonnarcotic Analgesics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Nonnarcotic Analgesics by Application
4.1 Nonnarcotic Analgesics Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Specialist Clinic
4.1.4 Other
4.2 Global Nonnarcotic Analgesics Market Size by Application
4.2.1 Global Nonnarcotic Analgesics Market Size Overview by Application (2018-2029)
4.2.2 Global Nonnarcotic Analgesics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Nonnarcotic Analgesics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nonnarcotic Analgesics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Nonnarcotic Analgesics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Nonnarcotic Analgesics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Nonnarcotic Analgesics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Nonnarcotic Analgesics Sales Breakdown by Application (2018-2024)
5 North America Nonnarcotic Analgesics by Country
5.1 North America Nonnarcotic Analgesics Historic Market Size by Country
5.1.1 North America Nonnarcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Nonnarcotic Analgesics Sales in Volume by Country (2018-2024)
5.1.3 North America Nonnarcotic Analgesics Sales in Value by Country (2018-2024)
5.2 North America Nonnarcotic Analgesics Forecasted Market Size by Country
5.2.1 North America Nonnarcotic Analgesics Sales in Volume by Country (2024-2029)
5.2.2 North America Nonnarcotic Analgesics Sales in Value by Country (2024-2029)
6 Europe Nonnarcotic Analgesics by Country
6.1 Europe Nonnarcotic Analgesics Historic Market Size by Country
6.1.1 Europe Nonnarcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Nonnarcotic Analgesics Sales in Volume by Country (2018-2024)
6.1.3 Europe Nonnarcotic Analgesics Sales in Value by Country (2018-2024)
6.2 Europe Nonnarcotic Analgesics Forecasted Market Size by Country
6.2.1 Europe Nonnarcotic Analgesics Sales in Volume by Country (2024-2029)
6.2.2 Europe Nonnarcotic Analgesics Sales in Value by Country (2024-2029)
7 Asia-Pacific Nonnarcotic Analgesics by Region
7.1 Asia-Pacific Nonnarcotic Analgesics Historic Market Size by Region
7.1.1 Asia-Pacific Nonnarcotic Analgesics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Nonnarcotic Analgesics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Nonnarcotic Analgesics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Nonnarcotic Analgesics Forecasted Market Size by Region
7.2.1 Asia-Pacific Nonnarcotic Analgesics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Nonnarcotic Analgesics Sales in Value by Region (2024-2029)
8 Latin America Nonnarcotic Analgesics by Country
8.1 Latin America Nonnarcotic Analgesics Historic Market Size by Country
8.1.1 Latin America Nonnarcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Nonnarcotic Analgesics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Nonnarcotic Analgesics Sales in Value by Country (2018-2024)
8.2 Latin America Nonnarcotic Analgesics Forecasted Market Size by Country
8.2.1 Latin America Nonnarcotic Analgesics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Nonnarcotic Analgesics Sales in Value by Country (2024-2029)
9 Middle East and Africa Nonnarcotic Analgesics by Country
9.1 Middle East and Africa Nonnarcotic Analgesics Historic Market Size by Country
9.1.1 Middle East and Africa Nonnarcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Nonnarcotic Analgesics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Nonnarcotic Analgesics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Nonnarcotic Analgesics Forecasted Market Size by Country
9.2.1 Middle East and Africa Nonnarcotic Analgesics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Nonnarcotic Analgesics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline Consumer Healthcare
10.1.1 GlaxoSmithKline Consumer Healthcare Company Information
10.1.2 GlaxoSmithKline Consumer Healthcare Introduction and Business Overview
10.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Products Offered
10.1.5 GlaxoSmithKline Consumer Healthcare Recent Development
10.2 Bayer Corporation
10.2.1 Bayer Corporation Company Information
10.2.2 Bayer Corporation Introduction and Business Overview
10.2.3 Bayer Corporation Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Corporation Nonnarcotic Analgesics Products Offered
10.2.5 Bayer Corporation Recent Development
10.3 Atnahs Pharma
10.3.1 Atnahs Pharma Company Information
10.3.2 Atnahs Pharma Introduction and Business Overview
10.3.3 Atnahs Pharma Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Atnahs Pharma Nonnarcotic Analgesics Products Offered
10.3.5 Atnahs Pharma Recent Development
10.4 Baudax Bio
10.4.1 Baudax Bio Company Information
10.4.2 Baudax Bio Introduction and Business Overview
10.4.3 Baudax Bio Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Baudax Bio Nonnarcotic Analgesics Products Offered
10.4.5 Baudax Bio Recent Development
10.5 Prestige Brands, Inc.
10.5.1 Prestige Brands, Inc. Company Information
10.5.2 Prestige Brands, Inc. Introduction and Business Overview
10.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Products Offered
10.5.5 Prestige Brands, Inc. Recent Development
10.6 Cumberland Pharmaceuticals, Inc.
10.6.1 Cumberland Pharmaceuticals, Inc. Company Information
10.6.2 Cumberland Pharmaceuticals, Inc. Introduction and Business Overview
10.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Products Offered
10.6.5 Cumberland Pharmaceuticals, Inc. Recent Development
10.7 Takeda Pharmaceutical Company
10.7.1 Takeda Pharmaceutical Company Company Information
10.7.2 Takeda Pharmaceutical Company Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Products Offered
10.7.5 Takeda Pharmaceutical Company Recent Development
10.8 Pfizer Inc.
10.8.1 Pfizer Inc. Company Information
10.8.2 Pfizer Inc. Introduction and Business Overview
10.8.3 Pfizer Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer Inc. Nonnarcotic Analgesics Products Offered
10.8.5 Pfizer Inc. Recent Development
10.9 McNeil Consumer Healthcare
10.9.1 McNeil Consumer Healthcare Company Information
10.9.2 McNeil Consumer Healthcare Introduction and Business Overview
10.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Products Offered
10.9.5 McNeil Consumer Healthcare Recent Development
10.10 Eli Lilly and Company
10.10.1 Eli Lilly and Company Company Information
10.10.2 Eli Lilly and Company Introduction and Business Overview
10.10.3 Eli Lilly and Company Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Eli Lilly and Company Nonnarcotic Analgesics Products Offered
10.10.5 Eli Lilly and Company Recent Development
10.11 Sun Pharmaceutical Industries
10.11.1 Sun Pharmaceutical Industries Company Information
10.11.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Products Offered
10.11.5 Sun Pharmaceutical Industries Recent Development
10.12 Validus Pharmaceuticals
10.12.1 Validus Pharmaceuticals Company Information
10.12.2 Validus Pharmaceuticals Introduction and Business Overview
10.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Products Offered
10.12.5 Validus Pharmaceuticals Recent Development
10.13 Novartis Consumer Health
10.13.1 Novartis Consumer Health Company Information
10.13.2 Novartis Consumer Health Introduction and Business Overview
10.13.3 Novartis Consumer Health Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Novartis Consumer Health Nonnarcotic Analgesics Products Offered
10.13.5 Novartis Consumer Health Recent Development
10.14 Pacira Pharmaceuticals, Inc.
10.14.1 Pacira Pharmaceuticals, Inc. Company Information
10.14.2 Pacira Pharmaceuticals, Inc. Introduction and Business Overview
10.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Products Offered
10.14.5 Pacira Pharmaceuticals, Inc. Recent Development
10.15 Almatica Pharma
10.15.1 Almatica Pharma Company Information
10.15.2 Almatica Pharma Introduction and Business Overview
10.15.3 Almatica Pharma Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Almatica Pharma Nonnarcotic Analgesics Products Offered
10.15.5 Almatica Pharma Recent Development
10.16 BioDelivery Sciences International, Inc.
10.16.1 BioDelivery Sciences International, Inc. Company Information
10.16.2 BioDelivery Sciences International, Inc. Introduction and Business Overview
10.16.3 BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.16.4 BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Products Offered
10.16.5 BioDelivery Sciences International, Inc. Recent Development
10.17 Akron, Inc.
10.17.1 Akron, Inc. Company Information
10.17.2 Akron, Inc. Introduction and Business Overview
10.17.3 Akron, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Akron, Inc. Nonnarcotic Analgesics Products Offered
10.17.5 Akron, Inc. Recent Development
10.18 Teva Pharmaceuticals, Inc.
10.18.1 Teva Pharmaceuticals, Inc. Company Information
10.18.2 Teva Pharmaceuticals, Inc. Introduction and Business Overview
10.18.3 Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Products Offered
10.18.5 Teva Pharmaceuticals, Inc. Recent Development
10.19 Heron Therapeutics
10.19.1 Heron Therapeutics Company Information
10.19.2 Heron Therapeutics Introduction and Business Overview
10.19.3 Heron Therapeutics Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Heron Therapeutics Nonnarcotic Analgesics Products Offered
10.19.5 Heron Therapeutics Recent Development
10.20 Assertio Therapeutics, Inc.
10.20.1 Assertio Therapeutics, Inc. Company Information
10.20.2 Assertio Therapeutics, Inc. Introduction and Business Overview
10.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Products Offered
10.20.5 Assertio Therapeutics, Inc. Recent Development
10.21 Sanofi s.A.
10.21.1 Sanofi s.A. Company Information
10.21.2 Sanofi s.A. Introduction and Business Overview
10.21.3 Sanofi s.A. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Sanofi s.A. Nonnarcotic Analgesics Products Offered
10.21.5 Sanofi s.A. Recent Development
10.22 Endo Pharmaceuticals
10.22.1 Endo Pharmaceuticals Company Information
10.22.2 Endo Pharmaceuticals Introduction and Business Overview
10.22.3 Endo Pharmaceuticals Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Endo Pharmaceuticals Nonnarcotic Analgesics Products Offered
10.22.5 Endo Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nonnarcotic Analgesics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nonnarcotic Analgesics Industrial Chain Analysis
11.4 Nonnarcotic Analgesics Market Dynamics
11.4.1 Nonnarcotic Analgesics Industry Trends
11.4.2 Nonnarcotic Analgesics Market Drivers
11.4.3 Nonnarcotic Analgesics Market Challenges
11.4.4 Nonnarcotic Analgesics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nonnarcotic Analgesics Distributors
12.3 Nonnarcotic Analgesics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Salicylates
Table 2. Major Company of Anilines
Table 3. Major Company of Pyrazolones
Table 4. Major Company of Other
Table 5. Global Nonnarcotic Analgesics Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Nonnarcotic Analgesics Sales by Type (2018-2024) & (K Units)
Table 7. Global Nonnarcotic Analgesics Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Nonnarcotic Analgesics Sales by Type (2018-2024) & (US& Million)
Table 9. Global Nonnarcotic Analgesics Market Share in Value by Type (2018-2024)
Table 10. Global Nonnarcotic Analgesics Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Nonnarcotic Analgesics Sales by Type (2024-2029) & (K Units)
Table 12. Global Nonnarcotic Analgesics Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Nonnarcotic Analgesics Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Nonnarcotic Analgesics Sales Market Share in Value by Type (2024-2029)
Table 15. Global Nonnarcotic Analgesics Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Nonnarcotic Analgesics Sales by Type (2018-2024) & (K Units)
Table 17. North America Nonnarcotic Analgesics Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Nonnarcotic Analgesics Sales (K Units) by Type (2018-2024)
Table 19. Europe Nonnarcotic Analgesics Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Nonnarcotic Analgesics Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Nonnarcotic Analgesics Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Nonnarcotic Analgesics Sales (K Units) by Type (2018-2024)
Table 23. Latin America Nonnarcotic Analgesics Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Nonnarcotic Analgesics Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Nonnarcotic Analgesics Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Nonnarcotic Analgesics Sales by Company (2018-2024) & (K Units)
Table 27. Global Nonnarcotic Analgesics Sales Share by Company (2018-2024)
Table 28. Global Nonnarcotic Analgesics Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Nonnarcotic Analgesics Revenue Share by Company (2018-2024)
Table 30. Global Market Nonnarcotic Analgesics Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Nonnarcotic Analgesics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Nonnarcotic Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nonnarcotic Analgesics as of 2022)
Table 34. Date of Key Manufacturers Enter into Nonnarcotic Analgesics Market
Table 35. Key Manufacturers Nonnarcotic Analgesics Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Nonnarcotic Analgesics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Nonnarcotic Analgesics Sales by Region (2018-2024) & (K Units)
Table 39. Global Nonnarcotic Analgesics Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Nonnarcotic Analgesics Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Nonnarcotic Analgesics Sales Market Share in Value by Region (2018-2024)
Table 42. Global Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Nonnarcotic Analgesics Sales by Region (2024-2029) & (K Units)
Table 44. Global Nonnarcotic Analgesics Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Nonnarcotic Analgesics Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Nonnarcotic Analgesics Sales Market Share in Value by Region (2024-2029)
Table 47. Global Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Nonnarcotic Analgesics Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Nonnarcotic Analgesics Sales by Application (2018-2024) & (K Units)
Table 50. Global Nonnarcotic Analgesics Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Nonnarcotic Analgesics Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Nonnarcotic Analgesics Sales Market Share in Value by Application (2018-2024)
Table 53. Global Nonnarcotic Analgesics Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Nonnarcotic Analgesics Sales by Application (2024-2029) & (K Units)
Table 55. Global Nonnarcotic Analgesics Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Nonnarcotic Analgesics Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Nonnarcotic Analgesics Sales Market Share in Value by Application (2024-2029)
Table 58. Global Nonnarcotic Analgesics Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Nonnarcotic Analgesics Sales by Application (2018-2024) (K Units)
Table 60. North America Nonnarcotic Analgesics Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Nonnarcotic Analgesics Sales by Application (2018-2024) (K Units)
Table 62. Europe Nonnarcotic Analgesics Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Nonnarcotic Analgesics Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Nonnarcotic Analgesics Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Nonnarcotic Analgesics Sales by Application (2018-2024) (K Units)
Table 66. Latin America Nonnarcotic Analgesics Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Nonnarcotic Analgesics Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Nonnarcotic Analgesics Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 70. North America Nonnarcotic Analgesics Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Nonnarcotic Analgesics Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Nonnarcotic Analgesics Sales Market Share in Value by Country (2018-2024)
Table 73. North America Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 74. North America Nonnarcotic Analgesics Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Nonnarcotic Analgesics Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Nonnarcotic Analgesics Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 78. Europe Nonnarcotic Analgesics Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Nonnarcotic Analgesics Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Nonnarcotic Analgesics Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 82. Europe Nonnarcotic Analgesics Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Nonnarcotic Analgesics Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Nonnarcotic Analgesics Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Nonnarcotic Analgesics Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Nonnarcotic Analgesics Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Nonnarcotic Analgesics Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Nonnarcotic Analgesics Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Nonnarcotic Analgesics Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Nonnarcotic Analgesics Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Nonnarcotic Analgesics Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Nonnarcotic Analgesics Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Nonnarcotic Analgesics Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Nonnarcotic Analgesics Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Value by Country (2024-2029)
Table 109. GlaxoSmithKline Consumer Healthcare Company Information
Table 110. GlaxoSmithKline Consumer Healthcare Introduction and Business Overview
Table 111. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product
Table 113. GlaxoSmithKline Consumer Healthcare Recent Development
Table 114. Bayer Corporation Company Information
Table 115. Bayer Corporation Introduction and Business Overview
Table 116. Bayer Corporation Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Bayer Corporation Nonnarcotic Analgesics Product
Table 118. Bayer Corporation Recent Development
Table 119. Atnahs Pharma Company Information
Table 120. Atnahs Pharma Introduction and Business Overview
Table 121. Atnahs Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Atnahs Pharma Nonnarcotic Analgesics Product
Table 123. Atnahs Pharma Recent Development
Table 124. Baudax Bio Company Information
Table 125. Baudax Bio Introduction and Business Overview
Table 126. Baudax Bio Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Baudax Bio Nonnarcotic Analgesics Product
Table 128. Baudax Bio Recent Development
Table 129. Prestige Brands, Inc. Company Information
Table 130. Prestige Brands, Inc. Introduction and Business Overview
Table 131. Prestige Brands, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Prestige Brands, Inc. Nonnarcotic Analgesics Product
Table 133. Prestige Brands, Inc. Recent Development
Table 134. Cumberland Pharmaceuticals, Inc. Company Information
Table 135. Cumberland Pharmaceuticals, Inc. Introduction and Business Overview
Table 136. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 138. Cumberland Pharmaceuticals, Inc. Recent Development
Table 139. Takeda Pharmaceutical Company Company Information
Table 140. Takeda Pharmaceutical Company Introduction and Business Overview
Table 141. Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product
Table 143. Takeda Pharmaceutical Company Recent Development
Table 144. Pfizer Inc. Company Information
Table 145. Pfizer Inc. Introduction and Business Overview
Table 146. Pfizer Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Pfizer Inc. Nonnarcotic Analgesics Product
Table 148. Pfizer Inc. Recent Development
Table 149. McNeil Consumer Healthcare Company Information
Table 150. McNeil Consumer Healthcare Introduction and Business Overview
Table 151. McNeil Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. McNeil Consumer Healthcare Nonnarcotic Analgesics Product
Table 153. McNeil Consumer Healthcare Recent Development
Table 154. Eli Lilly and Company Company Information
Table 155. Eli Lilly and Company Introduction and Business Overview
Table 156. Eli Lilly and Company Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Eli Lilly and Company Nonnarcotic Analgesics Product
Table 158. Eli Lilly and Company Recent Development
Table 159. Sun Pharmaceutical Industries Company Information
Table 160. Sun Pharmaceutical Industries Introduction and Business Overview
Table 161. Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product
Table 163. Sun Pharmaceutical Industries Recent Development
Table 164. Validus Pharmaceuticals Company Information
Table 165. Validus Pharmaceuticals Introduction and Business Overview
Table 166. Validus Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Validus Pharmaceuticals Nonnarcotic Analgesics Product
Table 168. Validus Pharmaceuticals Recent Development
Table 169. Novartis Consumer Health Company Information
Table 170. Novartis Consumer Health Introduction and Business Overview
Table 171. Novartis Consumer Health Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Novartis Consumer Health Nonnarcotic Analgesics Product
Table 173. Novartis Consumer Health Recent Development
Table 174. Pacira Pharmaceuticals, Inc. Company Information
Table 175. Pacira Pharmaceuticals, Inc. Introduction and Business Overview
Table 176. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 178. Pacira Pharmaceuticals, Inc. Recent Development
Table 179. Almatica Pharma Company Information
Table 180. Almatica Pharma Introduction and Business Overview
Table 181. Almatica Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Almatica Pharma Nonnarcotic Analgesics Product
Table 183. Almatica Pharma Recent Development
Table 184. BioDelivery Sciences International, Inc. Company Information
Table 185. BioDelivery Sciences International, Inc. Introduction and Business Overview
Table 186. BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Product
Table 188. BioDelivery Sciences International, Inc. Recent Development
Table 189. Akron, Inc. Company Information
Table 190. Akron, Inc. Introduction and Business Overview
Table 191. Akron, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Akron, Inc. Nonnarcotic Analgesics Product
Table 193. Akron, Inc. Recent Development
Table 194. Teva Pharmaceuticals, Inc. Company Information
Table 195. Teva Pharmaceuticals, Inc. Introduction and Business Overview
Table 196. Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 198. Teva Pharmaceuticals, Inc. Recent Development
Table 199. Heron Therapeutics Company Information
Table 200. Heron Therapeutics Introduction and Business Overview
Table 201. Heron Therapeutics Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Heron Therapeutics Nonnarcotic Analgesics Product
Table 203. Heron Therapeutics Recent Development
Table 204. Assertio Therapeutics, Inc. Company Information
Table 205. Assertio Therapeutics, Inc. Introduction and Business Overview
Table 206. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 207. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product
Table 208. Assertio Therapeutics, Inc. Recent Development
Table 209. Sanofi s.A. Company Information
Table 210. Sanofi s.A. Introduction and Business Overview
Table 211. Sanofi s.A. Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 212. Sanofi s.A. Nonnarcotic Analgesics Product
Table 213. Sanofi s.A. Recent Development
Table 214. Endo Pharmaceuticals Company Information
Table 215. Endo Pharmaceuticals Introduction and Business Overview
Table 216. Endo Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 217. Endo Pharmaceuticals Nonnarcotic Analgesics Product
Table 218. Endo Pharmaceuticals Recent Development
Table 219. Key Raw Materials Lists
Table 220. Raw Materials Key Suppliers Lists
Table 221. Nonnarcotic Analgesics Market Trends
Table 222. Nonnarcotic Analgesics Market Drivers
Table 223. Nonnarcotic Analgesics Market Challenges
Table 224. Nonnarcotic Analgesics Market Restraints
Table 225. Nonnarcotic Analgesics Distributors List
Table 226. Nonnarcotic Analgesics Downstream Customers
Table 227. Research Programs/Design for This Report
Table 228. Key Data Information from Secondary Sources
Table 229. Key Data Information from Primary Sources
List of Figures
Figure 1. Nonnarcotic Analgesics Product Picture
Figure 2. Global Nonnarcotic Analgesics Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Nonnarcotic Analgesics Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Nonnarcotic Analgesics Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Salicylates
Figure 6. Global Salicylates Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Anilines
Figure 8. Global Anilines Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Pyrazolones
Figure 10. Global Pyrazolones Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Nonnarcotic Analgesics Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Nonnarcotic Analgesics Sales Market Share by Type in 2022 & 2029
Figure 15. North America Nonnarcotic Analgesics Sales Market Share in Volume by Type in 2022
Figure 16. North America Nonnarcotic Analgesics Sales Market Share in Value by Type in 2022
Figure 17. Europe Nonnarcotic Analgesics Sales Market Share in Volume by Type in 2022
Figure 18. Europe Nonnarcotic Analgesics Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Value by Type in 2022
Figure 21. Latin America Nonnarcotic Analgesics Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Nonnarcotic Analgesics Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Nonnarcotic Analgesics Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Nonnarcotic Analgesics Revenue in 2022
Figure 27. Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Pharmacy
Figure 31. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Specialist Clinic
Figure 33. Global Specialist Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Nonnarcotic Analgesics Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Nonnarcotic Analgesics Sales Market Share by Application in 2022 & 2029
Figure 38. North America Nonnarcotic Analgesics Sales Market Share in Volume by Application in 2022
Figure 39. North America Nonnarcotic Analgesics Sales Market Share in Value by Application in 2022
Figure 40. Europe Nonnarcotic Analgesics Sales Market Share in Volume by Application in 2022
Figure 41. Europe Nonnarcotic Analgesics Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Nonnarcotic Analgesics Sales Market Share in Value by Application in 2022
Figure 44. Latin America Nonnarcotic Analgesics Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Nonnarcotic Analgesics Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Nonnarcotic Analgesics Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Nonnarcotic Analgesics Manufacturing Cost Structure
Figure 49. Nonnarcotic Analgesics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed